The CRISPR companies are not OK
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.
STAT Breakthrough Summit East | March 20, 2025 We’re committed to making STAT events accessible to as many attendees as possible. Our event scholarship
This cohort study of individuals with type 2 diabetes and overweight or obesity examined whether baseline Alzheimer disease blood-based biomarkers were associated with cognitive decline…
International Stroke Congress (ISC) Articles | JAMA Network International Stroke Conference (ISC) QUICK LINKS: Visit Us at ISC For Authors More Articles QUICK LINKS Visit…
International Stroke Congress (ISC) Articles | JAMA Network International Stroke Conference (ISC) QUICK LINKS: Visit Us at ISC For Authors More Articles QUICK LINKS Visit…
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about tuberculosis cases in the U.S.…
Learn how in some cases, persistent itchiness accompanied by other symptoms can be a sign of underlying conditions like diabetes, kidney disease or chronic liver…
The Trump Administration is halting all foreign aid and dismantling the United States Agency for International Development, the world’s largest single donor. And while USAID…
A new climate modeling study published in the journal Science Advances by researchers from the IBS Center for Climate Physics (ICCP) at Pusan National University…
This cohort study investigates whether incident hospital-based care (an emergency department [ED] visit or hospitalization) for cannabis use disorder is associated with increased risk of…
A new Mac app called RPLY launches today, designed to help texters achieve “inbox zero” on iMessage. Targeting those who often forget to reply and…